Table 2.
RE-AIM implementation outcomes
| Construct | Data source | Measure |
|---|---|---|
| Reach | • EHR data |
• Proportion of clinicians who accessed CV Prevention Choice • Characteristics of participants versus non-participants |
| Effectiveness |
• Clinician survey • Clinician interviews |
• Survey of attitudes about SDM [40] • Perceptions of effectiveness of CV Prevention Choice, and unintended consequences of its use |
| Adoption |
• EHR data • Clinician interviews |
• Proportion of eligible clinicians who used CV Prevention Choice • Factors affecting adoption of CV Prevention Choice and implementation strategies |
| Implementation (fidelity and challenges) |
• Video-recorded encounters • Post-encounter patient surveys • Clinician and stakeholder interviews • Periodic reflections and strategy tracking/change logs • Observations and workflow mapping |
• Fidelity checklist applied to video-recorded clinical encounters [25] • CARE Measure and Shared Decision Making Questionnaire-9 [61, 62] • Self-reported assessments of implementation challenges and adaptations to delivery |
| Maintenance and normalization |
• EHR data • Clinician survey |
• CV Prevention Choice use at start and end of implementation step-down stage • Repeated CV Prevention Choice use with the same patients |